NASDAQ · ORMPHealthcarePharmaceuticals

Oramed Pharmaceuticals news

$4.69−1.26%
Close Sep 29, 2026 · split-adjusted
Articles · 30 days0English, de-duplicated
Positive0
Neutral0
Negative0

About Oramed Pharmaceuticals

Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes
BenzingaJun 17, 8:55 AM ET▲ Positive

Inclusion in major Russell indexes is generally viewed positively as it increases visibility to institutional investors, typically leads to increased trading volume and liquidity, and validates the company's market position. Index inclusion often results in passive fund inflows as index funds rebalance to include the newly added security.

Also mentions ORMP

Articles that tag ORMP but are mainly about other companies.

None recently.

Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology